Mount Sinai Health System Launches First Enterprise-Wide Platform to Prescribe Apps to Patients
Researchers in the Sinai App Lab at the Icahn School of Medicine at Mount Sinai have developed RxUniverse, the first enterprise-wide digital medicine care delivery system that enables physicians to digitally prescribe evidence-based mobile health applications to patients at the point of care.
[See video for more information here]
With countless mobile health apps available to consumers, there is no standardized method for providers to know which ones will clinically benefit their patients, and no way for them to share them with patients directly. Through RxUniverse—which features a curated list of apps that have been evaluated for efficacy based on published evidence and incorporated into a digital prescription delivery system—Mount Sinai Health System aims to be the first provider network in the country to address this problem.
“RxUniverse allows physicians and other healthcare providers to seamlessly and confidently integrate evidence-based digital health tools into their practice,” said Ashish Atreja, MD, MPH, Chief Technology Innovation and Engagement Officer and Director of the Sinai AppLab, Icahn School of Medicine at Mount Sinai, “Apps have typically been recommended to patients verbally, but with the myriad of mobile health apps on the market, many with no proven evidence, it is a challenge for providers and patients. RxUniverse eliminates these uncertainties and barriers to digital medicine.”
The RxUniverse platform was launched in August 2016 in a pilot phase throughout five clinical areas at Mount Sinai. Since then, participating physicians have prescribed more than 2,000 apps, exceeding 20 times the pilot goal. In response to this success, the Sinai AppLab has partnered with Mount Sinai Innovation Partners to launch a new startup company, Responsive Health, which will license RxUniverse for use by other health systems.
“As the pace of innovation in digital medicine accelerates, there will be increasing demand for the ability to quickly integrate new apps into our health care systems,” said Kenneth L Davis, MD, President and CEO, Mount Sinai Health System. “Mount Sinai is proud to be at the forefront of digital medicine and dedicated to streamlining the eHealth care delivery model to further our mission to provide world-class care to our patients.”
RxUniverse is part of a larger ecosystem called the Network of Digital Evidence (NODE Health), which provides a community forum and structure for health system technology experts, digital medicine tech companies, clinicians and patients, to come together around digital medicine and the state of scientific evidence surrounding its design, efficacy, and implementation.
“RxUniverse will empower health care providers to bring multiple digital health tools directly to the hands of our patients quickly and reliably,” said Bruce Darrow, MD, PhD, Chief Medical Information Officer of the Mount Sinai Health System.
The applications for RxUniverse do not stop at mobile health apps. Specifically tailored educational content, patient satisfaction surveys, and other tools can be digitally prescribed to individual patients, or entire populations of people.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.